Valproic acid induces apoptosis in human leukemia cells by stimulating both caspase-dependent and -independent apoptotic signaling pathways
- 19 March 2002
- journal article
- Published by Elsevier BV in Leukemia Research
- Vol. 26 (5), 495-502
- https://doi.org/10.1016/s0145-2126(01)00151-5
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Effects of sodium butyrate on growth, differentiation, and apoptosis in head and neck squamous carcinoma cell linesHead & Neck, 2000
- E4orf4, a Novel Adenovirus Death Factor That Induces p53-independent Apoptosis by a Pathway That Is Not Inhibited by zVAD-fmkThe Journal of cell biology, 1998
- Antitumor activity of sodium valproate in cultures of human neuroblastoma cellsAnti-Cancer Drugs, 1996
- Role of short-chain fatty acids in the prevention of colorectal cancerEuropean Journal Of Cancer, 1995
- Bone marrow suppression induced by high dose valproic acid.Archives of Disease in Childhood, 1994
- In vitro differentiation of human neuroblastoma cells induced by sodium phenylacetateCancer Letters, 1993
- Segregation of the growth slowing effects of valproic acid from phenytoin and carbamazepine on lymphoid tumor cellsLife Sciences, 1992
- Establishment and characterization of a human acute monocytic leukemia cell line (THP‐1)International Journal of Cancer, 1980
- Acute Myelogenous Leukemia: A Human Cell Line Responsive to Colony-Stimulating ActivityScience, 1978
- IgD on cell membranes of human lymphoid cell lines with multiple immunoglobulin classesNature, 1974